Percent Weight Change in the Medical Supplement Group of Early Breast Cancer
Effects of Body Weight Change in the Medical Supplement Group in Patients with Early Breast Cancer During Chemotherapy: a Randomized, Controlled Trial
Department of Medical Services Ministry of Public Health of Thailand
40 participants
Jul 12, 2023
INTERVENTIONAL
Conditions
Summary
The goal of this RCT is to compare percent weight change in early breast cancer who takes medical supplement or not, during treatment with chemotherapy (standard AC regimen). The main question is • the change of weight (%) before and after complete treatment of breast cancer therapy. Participants will be randomized into 2 group * intervention group - receive medical supplement daily during chemotherapy treatment. * control group - Nutritional advise during chemotherapy treatment.
Eligibility
Inclusion Criteria4
- Histopathological confirmed diagnosis of breast cancer
- Breast cancer stage I-III
- Recieve adjuvant or neoadjuvant doxorubicin and cyclophosphamide at Rajavithi hospital
- LVEF \>= 60% - ECOG score 0-1
Exclusion Criteria11
- No indication for chemotherapy
- Contraindication for chemotherapy
- Breast cancer stage IV
- Diabetic mellitus who requires insulin injection
- BMI \>= 30 kg/m2 or \<= 16 kg/m2
- Previously known other malignancies
- Second primary cancer
- Previously received chemotherapy or radiotherapy
- Severe malnutrition with administration of TPN is indicated
- Pregnancy or lactation
- CKD stage 4-5
Interventions
Ensure 6 scoops dietary supplement powder in 250 ml of water, 2 drinks per days for 12 weeks.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06311357